ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 316 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $1,338,811 | +2.8% | 43,752 | -14.7% | 0.04% | 0.0% |
| Q1 2023 | $1,302,309 | -36.9% | 51,272 | +0.7% | 0.04% | -39.0% |
| Q4 2022 | $2,064,504 | +48.1% | 50,900 | +20.7% | 0.06% | +28.3% |
| Q3 2022 | $1,394,000 | -20.8% | 42,176 | -15.6% | 0.05% | -9.8% |
| Q2 2022 | $1,760,000 | -26.2% | 49,998 | -3.6% | 0.05% | +6.2% |
| Q1 2022 | $2,384,000 | +69.7% | 51,844 | +144.7% | 0.05% | +77.8% |
| Q4 2021 | $1,405,000 | -15.3% | 21,190 | -20.3% | 0.03% | -35.7% |
| Q3 2021 | $1,659,000 | -5.5% | 26,575 | +25.3% | 0.04% | -25.0% |
| Q2 2021 | $1,756,000 | +14.8% | 21,203 | -8.1% | 0.06% | -1.8% |
| Q1 2021 | $1,530,000 | – | 23,068 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Western Financial Corp/CA | 820,320 | $33,272,179 | 21.56% |
| Aquilo Capital Management, LLC | 1,103,515 | $44,758,568 | 16.81% |
| M28 Capital Management LP | 143,900 | $5,836,584 | 5.56% |
| WEALTH EFFECTS LLC | 155,620 | $6,311,951 | 3.60% |
| Evolutionary Tree Capital Management, LLC | 92,095 | $3,735,373 | 3.59% |
| Privium Fund Management B.V. | 221,015 | $8,867,122 | 3.36% |
| JOHNSON & JOHNSON | 247,598 | $10,043 | 2.92% |
| COMMODORE CAPITAL LP | 462,111 | $18,743 | 2.82% |
| Avidity Partners Management LP | 1,375,000 | $55,770,000 | 1.21% |
| Capital Impact Advisors, LLC | 26,853 | $1,089,158 | 1.06% |